ScienceDaily: Top Health News |
- T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity
- As pandemic progressed, people's perceived risks went up
- People's life goals relate to their personality type
- Epidemics and pandemics can exacerbate xenophobia, bigotry
- The unintended consequence of becoming empathetic
- A new discovery in regenerative medicine
- Building bridges: PARP enzymes bring broken DNA together
- Next-gen organoids grow and function like real tissues
- Brain circuitry underlying dissociative experiences
- Reprogramming brain cells enables flexible decision-making
- Researchers ask: how sustainable is your toothbrush?
- Replicating a genome starts with a twist, a pinch, and a bit of a dance
- Potential COVID-19 drug azithromycin may increase risk for cardiac events
- Factors inherent to obesity could increase vulnerability to COVID-19
- Better material for wearable biosensors
- Late childhood peer group status linked to heightened adult circulatory disease risk
- 1 in 10 COVID-19 patients return to hospital after being sent home from ER
- COVID-19 virus uses heparan sulfate to get inside cells
- Scientists uncover a novel approach to treating Duchenne muscular dystrophy
- 'COVID-19 is here to stay for the foreseeable future'
- COVID-19 measures deepening health inequalities in slum communities
- Certain coping strategies can help offset pandemic's mental health hits
T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity Posted: 16 Sep 2020 12:48 PM PDT A multi-layered, virus-specific immune response is important for controlling SARS-CoV-2 during the acute phase of the infection and reducing COVID-19 disease severity, with the bulk of the evidence pointing to a much bigger role for T cells than antibodies. A weak or uncoordinated immune response, on the other hand, predicts a poor disease outcome. |
As pandemic progressed, people's perceived risks went up Posted: 16 Sep 2020 12:48 PM PDT |
People's life goals relate to their personality type Posted: 16 Sep 2020 10:56 AM PDT |
Epidemics and pandemics can exacerbate xenophobia, bigotry Posted: 16 Sep 2020 10:11 AM PDT |
The unintended consequence of becoming empathetic Posted: 16 Sep 2020 10:10 AM PDT |
A new discovery in regenerative medicine Posted: 16 Sep 2020 08:35 AM PDT |
Building bridges: PARP enzymes bring broken DNA together Posted: 16 Sep 2020 08:35 AM PDT |
Next-gen organoids grow and function like real tissues Posted: 16 Sep 2020 08:35 AM PDT Bioengineers have created miniature intestines in a dish that match up anatomically and functionally to the real thing better than any other lab-grown tissue models. The biological complexity and longevity of the new organoid technology is an important step towards enabling drug testing, personalized medicine, and perhaps, one day, transplantations. |
Brain circuitry underlying dissociative experiences Posted: 16 Sep 2020 08:35 AM PDT |
Reprogramming brain cells enables flexible decision-making Posted: 16 Sep 2020 08:35 AM PDT Humans, like other animals, have the ability to constantly adapt to new situations. Researchers have utilized a mouse model to reveal which neurons in the brain are in command in guiding adaptive behavior. Their new study contributes to our understanding of decision-making processes in healthy and infirm people. |
Researchers ask: how sustainable is your toothbrush? Posted: 16 Sep 2020 08:34 AM PDT |
Replicating a genome starts with a twist, a pinch, and a bit of a dance Posted: 16 Sep 2020 08:34 AM PDT |
Potential COVID-19 drug azithromycin may increase risk for cardiac events Posted: 16 Sep 2020 08:34 AM PDT Azithromycin -- a commonly-prescribed antibiotic -- also is being investigated as a potential treatment for COVID-19. Researchers have found that azithromycin by itself is not associated with an increase in cardiac events; however, if the drug is taken with certain other drugs that affect the electrical functioning of the heart, then cardiac events increased. |
Factors inherent to obesity could increase vulnerability to COVID-19 Posted: 16 Sep 2020 06:42 AM PDT Conditions related to obesity, including inflammation and leaky gut, leave the lungs of obese patients more susceptible to COVID-19 and may explain why they are more likely to die from the disease, scientists say. They suggest that drugs used to lower inflammation in the lungs could prove beneficial to obese patients with the disease. |
Better material for wearable biosensors Posted: 16 Sep 2020 06:05 AM PDT |
Late childhood peer group status linked to heightened adult circulatory disease risk Posted: 15 Sep 2020 04:42 PM PDT |
1 in 10 COVID-19 patients return to hospital after being sent home from ER Posted: 15 Sep 2020 04:42 PM PDT |
COVID-19 virus uses heparan sulfate to get inside cells Posted: 15 Sep 2020 12:24 PM PDT |
Scientists uncover a novel approach to treating Duchenne muscular dystrophy Posted: 15 Sep 2020 06:01 AM PDT Scientists have shown that pharmacological (drug) correction of the content of extracellular vesicles released within dystrophic muscles can restore their ability to regenerate muscle and prevent muscle scarring. The study reveals a promising new therapeutic approach for Duchenne muscular dystrophy (DMD), an incurable muscle-wasting condition, and has far-reaching implications for the field of regenerative medicine. |
'COVID-19 is here to stay for the foreseeable future' Posted: 14 Sep 2020 08:22 AM PDT In a new paper, experts comment on the future of field-based sciences in a COVID-19 world. The piece outlines the epidemiological characteristics of SARS-CoV-2, the virus causing the COVID-19 pandemic, details its effects on field-based sciences and identifies how working practices can be remodeled to overcome the challenges brought on by the virus. |
COVID-19 measures deepening health inequalities in slum communities Posted: 14 Sep 2020 08:22 AM PDT |
Certain coping strategies can help offset pandemic's mental health hits Posted: 14 Sep 2020 08:21 AM PDT |
You are subscribed to email updates from Top Health News -- ScienceDaily. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States |